カテゴリー： QYResearch, 世界, 医療/バイオ

世界のダラツムマブ注射市場インサイト及び予測（100mg、400mg）

◆英語タイトル：Global Daratumumab Injection Market Insights, Forecast to 2028

QYResearchが発行した調査報告書（QY22JL3483）◆商品コード：QY22JL3483
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2022年7月（※2025年版があります。お問い合わせください。）
◆ページ数：73
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、ダラツムマブ注射のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にダラツムマブ注射の世界市場のxxx％を占める「100mg」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
ダラツムマブ注射の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのダラツムマブ注射市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

ダラツムマブ注射のグローバル主要企業には、Johnson & Johnson、Xi'an Janssen Pharmaceutical、Shanghai Henlius Biotechなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

ダラツムマブ注射市場は、種類と用途によって区分されます。世界のダラツムマブ注射市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
100mg、400mg

【用途別セグメント】
病院、クリニック、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- ダラツムマブ注射製品概要
- 種類別市場（100mg、400mg）
- 用途別市場（病院、クリニック、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のダラツムマブ注射販売量予測2017-2028
- 世界のダラツムマブ注射売上予測2017-2028
- ダラツムマブ注射の地域別販売量
- ダラツムマブ注射の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ダラツムマブ注射販売量
- 主要メーカー別ダラツムマブ注射売上
- 主要メーカー別ダラツムマブ注射価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（100mg、400mg）
- ダラツムマブ注射の種類別販売量
- ダラツムマブ注射の種類別売上
- ダラツムマブ注射の種類別価格
・用途別市場規模（病院、クリニック、その他）
- ダラツムマブ注射の用途別販売量
- ダラツムマブ注射の用途別売上
- ダラツムマブ注射の用途別価格
・北米市場
- 北米のダラツムマブ注射市場規模（種類別、用途別）
- 主要国別のダラツムマブ注射市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのダラツムマブ注射市場規模（種類別、用途別）
- 主要国別のダラツムマブ注射市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のダラツムマブ注射市場規模（種類別、用途別）
- 主要国別のダラツムマブ注射市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のダラツムマブ注射市場規模（種類別、用途別）
- 主要国別のダラツムマブ注射市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのダラツムマブ注射市場規模（種類別、用途別）
- 主要国別のダラツムマブ注射市場規模（トルコ、サウジアラビア）
・企業情報
Johnson & Johnson、Xi'an Janssen Pharmaceutical、Shanghai Henlius Biotech
・産業チェーン及び販売チャネル分析
- ダラツムマブ注射の産業チェーン分析
- ダラツムマブ注射の原材料
- ダラツムマブ注射の生産プロセス
- ダラツムマブ注射の販売及びマーケティング
- ダラツムマブ注射の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ダラツムマブ注射の産業動向
- ダラツムマブ注射のマーケットドライバー
- ダラツムマブ注射の課題
- ダラツムマブ注射の阻害要因
・主な調査結果

Market Analysis and Insights: Global Daratumumab Injection Market
The global Daratumumab Injection market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, 100 mg accounting for % of the Daratumumab Injection global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Daratumumab Injection market size is valued at US$ million in 2021, while the North America and Europe Daratumumab Injection are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Daratumumab Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Daratumumab Injection market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Daratumumab Injection market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Daratumumab Injection market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Daratumumab Injection market.
Global Daratumumab Injection Scope and Market Size
Daratumumab Injection market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Daratumumab Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
100 mg
400 mg
Segment by Application
Hospital
Clinic
Others
By Company
Johnson & Johnson
Xi’an Janssen Pharmaceutical
Shanghai Henlius Biotech
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Daratumumab Injection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 100 mg
1.2.3 400 mg
1.3 Market by Application
1.3.1 Global Daratumumab Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Daratumumab Injection Market Perspective (2017-2028)
2.2 Daratumumab Injection Growth Trends by Region
2.2.1 Daratumumab Injection Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Daratumumab Injection Historic Market Size by Region (2017-2022)
2.2.3 Daratumumab Injection Forecasted Market Size by Region (2023-2028)
2.3 Daratumumab Injection Market Dynamics
2.3.1 Daratumumab Injection Industry Trends
2.3.2 Daratumumab Injection Market Drivers
2.3.3 Daratumumab Injection Market Challenges
2.3.4 Daratumumab Injection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Daratumumab Injection Players by Revenue
3.1.1 Global Top Daratumumab Injection Players by Revenue (2017-2022)
3.1.2 Global Daratumumab Injection Revenue Market Share by Players (2017-2022)
3.2 Global Daratumumab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Daratumumab Injection Revenue
3.4 Global Daratumumab Injection Market Concentration Ratio
3.4.1 Global Daratumumab Injection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Daratumumab Injection Revenue in 2021
3.5 Daratumumab Injection Key Players Head office and Area Served
3.6 Key Players Daratumumab Injection Product Solution and Service
3.7 Date of Enter into Daratumumab Injection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Daratumumab Injection Breakdown Data by Type
4.1 Global Daratumumab Injection Historic Market Size by Type (2017-2022)
4.2 Global Daratumumab Injection Forecasted Market Size by Type (2023-2028)
5 Daratumumab Injection Breakdown Data by Application
5.1 Global Daratumumab Injection Historic Market Size by Application (2017-2022)
5.2 Global Daratumumab Injection Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Daratumumab Injection Market Size (2017-2028)
6.2 North America Daratumumab Injection Market Size by Type
6.2.1 North America Daratumumab Injection Market Size by Type (2017-2022)
6.2.2 North America Daratumumab Injection Market Size by Type (2023-2028)
6.2.3 North America Daratumumab Injection Market Share by Type (2017-2028)
6.3 North America Daratumumab Injection Market Size by Application
6.3.1 North America Daratumumab Injection Market Size by Application (2017-2022)
6.3.2 North America Daratumumab Injection Market Size by Application (2023-2028)
6.3.3 North America Daratumumab Injection Market Share by Application (2017-2028)
6.4 North America Daratumumab Injection Market Size by Country
6.4.1 North America Daratumumab Injection Market Size by Country (2017-2022)
6.4.2 North America Daratumumab Injection Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Daratumumab Injection Market Size (2017-2028)
7.2 Europe Daratumumab Injection Market Size by Type
7.2.1 Europe Daratumumab Injection Market Size by Type (2017-2022)
7.2.2 Europe Daratumumab Injection Market Size by Type (2023-2028)
7.2.3 Europe Daratumumab Injection Market Share by Type (2017-2028)
7.3 Europe Daratumumab Injection Market Size by Application
7.3.1 Europe Daratumumab Injection Market Size by Application (2017-2022)
7.3.2 Europe Daratumumab Injection Market Size by Application (2023-2028)
7.3.3 Europe Daratumumab Injection Market Share by Application (2017-2028)
7.4 Europe Daratumumab Injection Market Size by Country
7.4.1 Europe Daratumumab Injection Market Size by Country (2017-2022)
7.4.2 Europe Daratumumab Injection Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Daratumumab Injection Market Size (2017-2028)
8.2 Asia-Pacific Daratumumab Injection Market Size by Type
8.2.1 Asia-Pacific Daratumumab Injection Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Daratumumab Injection Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Daratumumab Injection Market Share by Type (2017-2028)
8.3 Asia-Pacific Daratumumab Injection Market Size by Application
8.3.1 Asia-Pacific Daratumumab Injection Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Daratumumab Injection Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Daratumumab Injection Market Share by Application (2017-2028)
8.4 Asia-Pacific Daratumumab Injection Market Size by Region
8.4.1 Asia-Pacific Daratumumab Injection Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Daratumumab Injection Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Daratumumab Injection Market Size (2017-2028)
9.2 Latin America Daratumumab Injection Market Size by Type
9.2.1 Latin America Daratumumab Injection Market Size by Type (2017-2022)
9.2.2 Latin America Daratumumab Injection Market Size by Type (2023-2028)
9.2.3 Latin America Daratumumab Injection Market Share by Type (2017-2028)
9.3 Latin America Daratumumab Injection Market Size by Application
9.3.1 Latin America Daratumumab Injection Market Size by Application (2017-2022)
9.3.2 Latin America Daratumumab Injection Market Size by Application (2023-2028)
9.3.3 Latin America Daratumumab Injection Market Share by Application (2017-2028)
9.4 Latin America Daratumumab Injection Market Size by Country
9.4.1 Latin America Daratumumab Injection Market Size by Country (2017-2022)
9.4.2 Latin America Daratumumab Injection Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Daratumumab Injection Market Size (2017-2028)
10.2 Middle East & Africa Daratumumab Injection Market Size by Type
10.2.1 Middle East & Africa Daratumumab Injection Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Daratumumab Injection Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Daratumumab Injection Market Share by Type (2017-2028)
10.3 Middle East & Africa Daratumumab Injection Market Size by Application
10.3.1 Middle East & Africa Daratumumab Injection Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Daratumumab Injection Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Daratumumab Injection Market Share by Application (2017-2028)
10.4 Middle East & Africa Daratumumab Injection Market Size by Country
10.4.1 Middle East & Africa Daratumumab Injection Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Daratumumab Injection Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Daratumumab Injection Introduction
11.1.4 Johnson & Johnson Revenue in Daratumumab Injection Business (2017-2022)
11.1.5 Johnson & Johnson Recent Developments
11.2 Xi’an Janssen Pharmaceutical
11.2.1 Xi’an Janssen Pharmaceutical Company Details
11.2.2 Xi’an Janssen Pharmaceutical Business Overview
11.2.3 Xi’an Janssen Pharmaceutical Daratumumab Injection Introduction
11.2.4 Xi’an Janssen Pharmaceutical Revenue in Daratumumab Injection Business (2017-2022)
11.2.5 Xi’an Janssen Pharmaceutical Recent Developments
11.3 Shanghai Henlius Biotech
11.3.1 Shanghai Henlius Biotech Company Details
11.3.2 Shanghai Henlius Biotech Business Overview
11.3.3 Shanghai Henlius Biotech Daratumumab Injection Introduction
11.3.4 Shanghai Henlius Biotech Revenue in Daratumumab Injection Business (2017-2022)
11.3.5 Shanghai Henlius Biotech Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Daratumumab Injection Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of 100 mg
Table 3. Key Players of 400 mg
Table 4. Global Daratumumab Injection Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Daratumumab Injection Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Daratumumab Injection Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Daratumumab Injection Market Share by Region (2017-2022)
Table 8. Global Daratumumab Injection Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Daratumumab Injection Market Share by Region (2023-2028)
Table 10. Daratumumab Injection Market Trends
Table 11. Daratumumab Injection Market Drivers
Table 12. Daratumumab Injection Market Challenges
Table 13. Daratumumab Injection Market Restraints
Table 14. Global Daratumumab Injection Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Daratumumab Injection Revenue Share by Players (2017-2022)
Table 16. Global Top Daratumumab Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Daratumumab Injection as of 2021)
Table 17. Ranking of Global Top Daratumumab Injection Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Daratumumab Injection Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Daratumumab Injection Product Solution and Service
Table 21. Date of Enter into Daratumumab Injection Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Daratumumab Injection Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Daratumumab Injection Revenue Market Share by Type (2017-2022)
Table 25. Global Daratumumab Injection Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Daratumumab Injection Revenue Market Share by Type (2023-2028)
Table 27. Global Daratumumab Injection Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Daratumumab Injection Revenue Share by Application (2017-2022)
Table 29. Global Daratumumab Injection Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Daratumumab Injection Revenue Share by Application (2023-2028)
Table 31. North America Daratumumab Injection Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Daratumumab Injection Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Daratumumab Injection Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Daratumumab Injection Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Daratumumab Injection Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Daratumumab Injection Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Daratumumab Injection Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Daratumumab Injection Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Daratumumab Injection Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Daratumumab Injection Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Daratumumab Injection Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Daratumumab Injection Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Daratumumab Injection Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Daratumumab Injection Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Daratumumab Injection Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Daratumumab Injection Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Daratumumab Injection Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Daratumumab Injection Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Daratumumab Injection Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Daratumumab Injection Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Daratumumab Injection Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Daratumumab Injection Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Daratumumab Injection Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Daratumumab Injection Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Daratumumab Injection Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Daratumumab Injection Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Daratumumab Injection Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Daratumumab Injection Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Daratumumab Injection Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Daratumumab Injection Market Size by Country (2023-2028) & (US$ Million)
Table 61. Johnson & Johnson Company Details
Table 62. Johnson & Johnson Business Overview
Table 63. Johnson & Johnson Daratumumab Injection Product
Table 64. Johnson & Johnson Revenue in Daratumumab Injection Business (2017-2022) & (US$ Million)
Table 65. Johnson & Johnson Recent Developments
Table 66. Xi'an Janssen Pharmaceutical Company Details
Table 67. Xi'an Janssen Pharmaceutical Business Overview
Table 68. Xi'an Janssen Pharmaceutical Daratumumab Injection Product
Table 69. Xi'an Janssen Pharmaceutical Revenue in Daratumumab Injection Business (2017-2022) & (US$ Million)
Table 70. Xi'an Janssen Pharmaceutical Recent Developments
Table 71. Shanghai Henlius Biotech Company Details
Table 72. Shanghai Henlius Biotech Business Overview
Table 73. Shanghai Henlius Biotech Daratumumab Injection Product
Table 74. Shanghai Henlius Biotech Revenue in Daratumumab Injection Business (2017-2022) & (US$ Million)
Table 75. Shanghai Henlius Biotech Recent Developments
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Daratumumab Injection Market Share by Type: 2021 VS 2028
Figure 2. 100 mg Features
Figure 3. 400 mg Features
Figure 4. Global Daratumumab Injection Market Share by Application: 2021 VS 2028
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Daratumumab Injection Report Years Considered
Figure 9. Global Daratumumab Injection Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Daratumumab Injection Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Daratumumab Injection Market Share by Region: 2021 VS 2028
Figure 12. Global Daratumumab Injection Market Share by Players in 2021
Figure 13. Global Top Daratumumab Injection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Daratumumab Injection as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Daratumumab Injection Revenue in 2021
Figure 15. North America Daratumumab Injection Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Daratumumab Injection Market Size Market Share by Type (2017-2028)
Figure 17. North America Daratumumab Injection Market Size Market Share by Application (2017-2028)
Figure 18. North America Daratumumab Injection Market Size Share by Country (2017-2028)
Figure 19. United States Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Daratumumab Injection Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Daratumumab Injection Market Size Market Share by Type (2017-2028)
Figure 23. Europe Daratumumab Injection Market Size Market Share by Application (2017-2028)
Figure 24. Europe Daratumumab Injection Market Size Share by Country (2017-2028)
Figure 25. Germany Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Daratumumab Injection Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Daratumumab Injection Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Daratumumab Injection Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Daratumumab Injection Market Size Share by Region (2017-2028)
Figure 35. China Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Daratumumab Injection Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Daratumumab Injection Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Daratumumab Injection Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Daratumumab Injection Market Size Share by Country (2017-2028)
Figure 45. Mexico Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Daratumumab Injection Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Daratumumab Injection Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Daratumumab Injection Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Daratumumab Injection Market Size Share by Country (2017-2028)
Figure 51. Turkey Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Johnson & Johnson Revenue Growth Rate in Daratumumab Injection Business (2017-2022)
Figure 55. Xi'an Janssen Pharmaceutical Revenue Growth Rate in Daratumumab Injection Business (2017-2022)
Figure 56. Shanghai Henlius Biotech Revenue Growth Rate in Daratumumab Injection Business (2017-2022)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界のダラツムマブ注射市場インサイト及び予測（100mg、400mg）(Global Daratumumab Injection Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界のオラパリブ薬市場インサイト及び予測（100mg、150mg）
  • 世界のイマチニブメシル酸塩錠市場インサイト及び予測（100mg、400mg）
  • 世界のグセルクマブ注射市場インサイト及び予測（100mg、その他）
  • 世界のウデナフィル市場インサイト及び予測（100mg、200mg）
  • 世界のエプロサルタンメシレート市場インサイト及び予測（200mg、400mg）